Protein Kinase A Regulates Platelet Phosphodiesterase 3A through an A-Kinase Anchoring Protein Dependent Manner
Cells · 2024
DOI: 10.3390/cells13131104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Jawad S Khalil und 7 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Cardiovascular & Metabolic Medicine, University of Leeds, Leeds LS2 9JT, UK. Hauptthemen laut MEDLINE: Cyclic Nucleotide Phosphodiesterases, Type 3, Blood Platelets, A Kinase Anchor Proteins, Cyclic AMP-Dependent Protein Kinases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation.
Abstract (Originalsprache)
Platelet activation is critical for haemostasis, but if unregulated can lead to pathological thrombosis. Endogenous platelet inhibitory mechanisms are mediated by prostacyclin (PGI2)-stimulated cAMP signalling, which is regulated by phosphodiesterase 3A (PDE3A). However, spatiotemporal regulation of PDE3A activity in platelets is unknown. Here, we report that platelets possess multiple PDE3A isoforms with seemingly identical molecular weights (100 kDa). One isoform contained a unique N-terminal sequence that corresponded to PDE3A1 in nucleated cells but with negligible contribution to overall PDE3A activity. The predominant cytosolic PDE3A isoform did not possess the unique N-terminal sequence and accounted for >99% of basal PDE3A activity. PGI2 treatment induced a dose and time-dependent increase in PDE3A phosphorylation which was PKA-dependent and associated with an increase in phosphodiesterase enzymatic activity. The effects of PGI2 on PDE3A were modulated by A-kinase anchoring protein (AKAP) disruptor peptides, suggesting an AKAP-mediated PDE3A signalosome. We identified AKAP7, AKAP9, AKAP12, AKAP13, and moesin expressed in platelets but focussed on AKAP7 as a potential PDE3A binding partner. Using a combination of immunoprecipitation, proximity ligation techniques, and activity assays, we identified a novel PDE3A/PKA RII/AKAP7 signalosome in platelets that integrates propagation and termination of cAMP signalling through coupling of PKA and PDE3A.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leeds Institute of Cardiovascular & Metabolic Medicine, University of Leeds, Leeds LS2 9JT, UK.
- Hull York Medical School, University of Hull, Hull HU6 7EL, UK.
ORCID-Profile: Matthew S Hindle
Förderung
- British Heart Foundation
Zitieren
APA
Khalil, J. S., Law, R., Raslan, Z., Cheah, L. T., Hindle, M. S., Aburima, A. A., Kearney, M. T., & Naseem, K. M. (2024). Protein Kinase A Regulates Platelet Phosphodiesterase 3A through an A-Kinase Anchoring Protein Dependent Manner. Cells. https://doi.org/10.3390/cells13131104
Vancouver
Khalil JS, Law R, Raslan Z, Cheah LT, Hindle MS, Aburima AA, et al. Protein Kinase A Regulates Platelet Phosphodiesterase 3A through an A-Kinase Anchoring Protein Dependent Manner. Cells. 2024. doi:10.3390/cells13131104
BibTeX
@article{Khalil2024,
author = {Khalil, Jawad S and Law, Robert and Raslan, Zaher and Cheah, Lih T and Hindle, Matthew S and Aburima, Ahmed A and Kearney, Mark T and Naseem, Khalid M},
title = {Protein Kinase A Regulates Platelet Phosphodiesterase 3A through an A-Kinase Anchoring Protein Dependent Manner},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13131104}
}
EUVIMED